10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-019666`
Period End Date	20230331
Filing Date	20230509
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	agl-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 46 Cash Flow Statement 44 Stockholders Equity 20 Comprehensive Income 12

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$497.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$394.19M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$10.61M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$10.20M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$411.90M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$422.49M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$1.00B	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$497.57M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$44.70M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$34.12M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	412.38M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	414.46M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.45B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.88B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	414.46M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$20.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.13M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Assets	`Assets`	$1.70B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$67.68M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$92.71M	USD	Point-in-time
Assets	`Assets`	$2.17B	USD	Point-in-time
Goodwill	`Goodwill`	$62.14M	USD	Point-in-time
Liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Liabilities	`Liabilities`	$1.09B	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$116.85M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$116.92M	USD	Point-in-time
Total assets	`Assets`	$1.70B	USD	Point-in-time
Total assets	`Assets`	$2.17B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$745.56M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$346.73M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$222.05M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$183.36M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$535.09M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$972.61M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$37.25M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$38.48M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$83.29M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$78.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.09B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 414,465 and 412,385 shares issued and outstanding, respectively	`CommonStockValue`	$4.14M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 414,465 and 412,385 shares issued and outstanding, respectively	`CommonStockValue`	$4.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.13B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.11B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.05B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.56M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.55M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.08B	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.04B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-611.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-674.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.70B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$2.17B	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$3.97M	USD	1 Quarter
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$13.67M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$653.45M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.14B	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$972.83M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$566.21M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$86.02M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$44.77M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $13,672 and $3,970, respectively)	`GeneralAndAdministrativeExpense`	$39.83M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $13,672 and $3,970, respectively)	`GeneralAndAdministrativeExpense`	$66.85M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$4.19M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.37M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$654.19M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.13B	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$6.26M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-743.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$2.27M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$9.47M	USD	1 Quarter
Interest expense	`InterestExpense`	$871.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.53M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$655.00K	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$14.20M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-1.76M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-71.00K	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$726.00K	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$15.96M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$429.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$15.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$63.00K	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$75.00K	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$1.23M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$16.02M	USD	1 Quarter
Net income (loss) per common share from continuing operations, basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.04	USD	1 Quarter
Net income (loss) per common share from continuing operations, basic	`IncomeLossFromContinuingOperationsPerBasicShare`	-	USD	1 Quarter
Net income (loss) per common share from continuing operations, diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	-	USD	1 Quarter
Net income (loss) per common share from continuing operations, diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.04	USD	1 Quarter
Net income (loss) per common share from discontinued operations, basic	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income (loss) per common share from discontinued operations, basic	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income (loss) per common share from discontinued operations, basic	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Net income (loss) per common share from discontinued operations, basic	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	401.96M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	413.14M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	424.06M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	426.59M	shares	1 Quarter

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$15.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.19M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.37M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$13.67M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.97M	USD	1 Quarter
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.03M	USD	1 Quarter
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.38M	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$1.78M	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$-556.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$30.25M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$91.47M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-60.81M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.23M	USD	1 Quarter
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.05M	USD	1 Quarter
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.72M	USD	1 Quarter
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$1.00M	USD	1 Quarter
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	1 Quarter
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$4.50M	USD	1 Quarter
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$1.30M	USD	1 Quarter
Investments in marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$29.97M	USD	1 Quarter
Investments in marketable debt securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$28.54M	USD	1 Quarter
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$683.00K	USD	1 Quarter
Net cash paid in business combination	`NetCashPaidInBusinessCombination`	-	USD	1 Quarter
Net cash paid in business combination	`NetCashPaidInBusinessCombination`	$-44.37M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.87M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-50.81M	USD	1 Quarter
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$14.76M	USD	1 Quarter
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$9.59M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.25M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.25M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.51M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.34M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-103.29M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-18.60M	USD	1 Quarter
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$404.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$404.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.04B	USD	Point-in-time

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	414.46M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$15.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.62M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$14.76M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.01M	USD	1 Quarter
Shares withheld related to net share settlement	`SharesPaidForTaxWithholdingForShareBasedCompensation`	28.00	shares	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.97M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.67M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	414.46M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$15.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes`	$1.90M	USD	1 Quarter
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes`	-	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$115.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	-	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.16M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$17.97M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-63.00K	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-75.00K	USD	1 Quarter
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$18.03M	USD	1 Quarter
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$1.23M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.